The global Peripheral Chronic Total Occlusion Device market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Peripheral Chronic Total Occlusion Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Peripheral Chronic Total Occlusion Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Peripheral Chronic Total Occlusion Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Peripheral Chronic Total Occlusion Device include Medtronic Plc, Boston Scientific Corporation, Avinger, Inc., Cardinal Health, Koninklijke Philips N.V., Cook Medical Incorporated, C.R. Bard, Baylis Medical Company and BTG Vascular, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Peripheral Chronic Total Occlusion Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Peripheral Chronic Total Occlusion Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Peripheral Chronic Total Occlusion Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Peripheral Chronic Total Occlusion Device sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Peripheral Chronic Total Occlusion Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Peripheral Chronic Total Occlusion Device sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic Plc, Boston Scientific Corporation, Avinger, Inc., Cardinal Health, Koninklijke Philips N.V., Cook Medical Incorporated, C.R. Bard, Baylis Medical Company and BTG Vascular, etc.
By Company
Medtronic Plc
Boston Scientific Corporation
Avinger, Inc.
Cardinal Health
Koninklijke Philips N.V.
Cook Medical Incorporated
C.R. Bard
Baylis Medical Company
BTG Vascular
Soundbite Medical Solutions
Segment by Type
Micro Catheters
Guide Wires
Crossing Devices
Re-entry Devices
Segment by Application
Hospital
Clinic
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Peripheral Chronic Total Occlusion Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Peripheral Chronic Total Occlusion Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peripheral Chronic Total Occlusion Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Peripheral Chronic Total Occlusion Device Product Introduction
1.2 Market by Type
1.2.1 Global Peripheral Chronic Total Occlusion Device Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Micro Catheters
1.2.3 Guide Wires
1.2.4 Crossing Devices
1.2.5 Re-entry Devices
1.3 Market by Application
1.3.1 Global Peripheral Chronic Total Occlusion Device Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Peripheral Chronic Total Occlusion Device Sales Estimates and Forecasts 2018-2029
2.2 Global Peripheral Chronic Total Occlusion Device Revenue by Region
2.2.1 Global Peripheral Chronic Total Occlusion Device Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Peripheral Chronic Total Occlusion Device Revenue by Region (2018-2023)
2.2.3 Global Peripheral Chronic Total Occlusion Device Revenue by Region (2024-2029)
2.2.4 Global Peripheral Chronic Total Occlusion Device Revenue Market Share by Region (2018-2029)
2.3 Global Peripheral Chronic Total Occlusion Device Sales Estimates and Forecasts 2018-2029
2.4 Global Peripheral Chronic Total Occlusion Device Sales by Region
2.4.1 Global Peripheral Chronic Total Occlusion Device Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Peripheral Chronic Total Occlusion Device Sales by Region (2018-2023)
2.4.3 Global Peripheral Chronic Total Occlusion Device Sales by Region (2024-2029)
2.4.4 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Peripheral Chronic Total Occlusion Device Sales by Manufacturers
3.1.1 Global Peripheral Chronic Total Occlusion Device Sales by Manufacturers (2018-2023)
3.1.2 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peripheral Chronic Total Occlusion Device in 2022
3.2 Global Peripheral Chronic Total Occlusion Device Revenue by Manufacturers
3.2.1 Global Peripheral Chronic Total Occlusion Device Revenue by Manufacturers (2018-2023)
3.2.2 Global Peripheral Chronic Total Occlusion Device Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Peripheral Chronic Total Occlusion Device Revenue in 2022
3.3 Global Key Players of Peripheral Chronic Total Occlusion Device, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Peripheral Chronic Total Occlusion Device Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Peripheral Chronic Total Occlusion Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Peripheral Chronic Total Occlusion Device, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Peripheral Chronic Total Occlusion Device, Product Offered and Application
3.8 Global Key Manufacturers of Peripheral Chronic Total Occlusion Device, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peripheral Chronic Total Occlusion Device Sales by Type
4.1.1 Global Peripheral Chronic Total Occlusion Device Historical Sales by Type (2018-2023)
4.1.2 Global Peripheral Chronic Total Occlusion Device Forecasted Sales by Type (2024-2029)
4.1.3 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Type (2018-2029)
4.2 Global Peripheral Chronic Total Occlusion Device Revenue by Type
4.2.1 Global Peripheral Chronic Total Occlusion Device Historical Revenue by Type (2018-2023)
4.2.2 Global Peripheral Chronic Total Occlusion Device Forecasted Revenue by Type (2024-2029)
4.2.3 Global Peripheral Chronic Total Occlusion Device Revenue Market Share by Type (2018-2029)
4.3 Global Peripheral Chronic Total Occlusion Device Price by Type
4.3.1 Global Peripheral Chronic Total Occlusion Device Price by Type (2018-2023)
4.3.2 Global Peripheral Chronic Total Occlusion Device Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Peripheral Chronic Total Occlusion Device Sales by Application
5.1.1 Global Peripheral Chronic Total Occlusion Device Historical Sales by Application (2018-2023)
5.1.2 Global Peripheral Chronic Total Occlusion Device Forecasted Sales by Application (2024-2029)
5.1.3 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Application (2018-2029)
5.2 Global Peripheral Chronic Total Occlusion Device Revenue by Application
5.2.1 Global Peripheral Chronic Total Occlusion Device Historical Revenue by Application (2018-2023)
5.2.2 Global Peripheral Chronic Total Occlusion Device Forecasted Revenue by Application (2024-2029)
5.2.3 Global Peripheral Chronic Total Occlusion Device Revenue Market Share by Application (2018-2029)
5.3 Global Peripheral Chronic Total Occlusion Device Price by Application
5.3.1 Global Peripheral Chronic Total Occlusion Device Price by Application (2018-2023)
5.3.2 Global Peripheral Chronic Total Occlusion Device Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Peripheral Chronic Total Occlusion Device Market Size by Type
6.1.1 US & Canada Peripheral Chronic Total Occlusion Device Sales by Type (2018-2029)
6.1.2 US & Canada Peripheral Chronic Total Occlusion Device Revenue by Type (2018-2029)
6.2 US & Canada Peripheral Chronic Total Occlusion Device Market Size by Application
6.2.1 US & Canada Peripheral Chronic Total Occlusion Device Sales by Application (2018-2029)
6.2.2 US & Canada Peripheral Chronic Total Occlusion Device Revenue by Application (2018-2029)
6.3 US & Canada Peripheral Chronic Total Occlusion Device Market Size by Country
6.3.1 US & Canada Peripheral Chronic Total Occlusion Device Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Peripheral Chronic Total Occlusion Device Sales by Country (2018-2029)
6.3.3 US & Canada Peripheral Chronic Total Occlusion Device Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Peripheral Chronic Total Occlusion Device Market Size by Type
7.1.1 Europe Peripheral Chronic Total Occlusion Device Sales by Type (2018-2029)
7.1.2 Europe Peripheral Chronic Total Occlusion Device Revenue by Type (2018-2029)
7.2 Europe Peripheral Chronic Total Occlusion Device Market Size by Application
7.2.1 Europe Peripheral Chronic Total Occlusion Device Sales by Application (2018-2029)
7.2.2 Europe Peripheral Chronic Total Occlusion Device Revenue by Application (2018-2029)
7.3 Europe Peripheral Chronic Total Occlusion Device Market Size by Country
7.3.1 Europe Peripheral Chronic Total Occlusion Device Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Peripheral Chronic Total Occlusion Device Sales by Country (2018-2029)
7.3.3 Europe Peripheral Chronic Total Occlusion Device Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Peripheral Chronic Total Occlusion Device Market Size
8.1.1 China Peripheral Chronic Total Occlusion Device Sales (2018-2029)
8.1.2 China Peripheral Chronic Total Occlusion Device Revenue (2018-2029)
8.2 China Peripheral Chronic Total Occlusion Device Market Size by Application
8.2.1 China Peripheral Chronic Total Occlusion Device Sales by Application (2018-2029)
8.2.2 China Peripheral Chronic Total Occlusion Device Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Peripheral Chronic Total Occlusion Device Market Size by Type
9.1.1 Asia Peripheral Chronic Total Occlusion Device Sales by Type (2018-2029)
9.1.2 Asia Peripheral Chronic Total Occlusion Device Revenue by Type (2018-2029)
9.2 Asia Peripheral Chronic Total Occlusion Device Market Size by Application
9.2.1 Asia Peripheral Chronic Total Occlusion Device Sales by Application (2018-2029)
9.2.2 Asia Peripheral Chronic Total Occlusion Device Revenue by Application (2018-2029)
9.3 Asia Peripheral Chronic Total Occlusion Device Sales by Region
9.3.1 Asia Peripheral Chronic Total Occlusion Device Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Peripheral Chronic Total Occlusion Device Revenue by Region (2018-2029)
9.3.3 Asia Peripheral Chronic Total Occlusion Device Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Market Size by Type
10.1.1 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Market Size by Application
10.2.1 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Sales by Country
10.3.1 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Peripheral Chronic Total Occlusion Device Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Medtronic Plc
11.1.1 Medtronic Plc Company Information
11.1.2 Medtronic Plc Overview
11.1.3 Medtronic Plc Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Medtronic Plc Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Plc Recent Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Information
11.2.2 Boston Scientific Corporation Overview
11.2.3 Boston Scientific Corporation Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Boston Scientific Corporation Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boston Scientific Corporation Recent Developments
11.3 Avinger, Inc.
11.3.1 Avinger, Inc. Company Information
11.3.2 Avinger, Inc. Overview
11.3.3 Avinger, Inc. Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Avinger, Inc. Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Avinger, Inc. Recent Developments
11.4 Cardinal Health
11.4.1 Cardinal Health Company Information
11.4.2 Cardinal Health Overview
11.4.3 Cardinal Health Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Cardinal Health Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cardinal Health Recent Developments
11.5 Koninklijke Philips N.V.
11.5.1 Koninklijke Philips N.V. Company Information
11.5.2 Koninklijke Philips N.V. Overview
11.5.3 Koninklijke Philips N.V. Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Koninklijke Philips N.V. Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Koninklijke Philips N.V. Recent Developments
11.6 Cook Medical Incorporated
11.6.1 Cook Medical Incorporated Company Information
11.6.2 Cook Medical Incorporated Overview
11.6.3 Cook Medical Incorporated Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Cook Medical Incorporated Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cook Medical Incorporated Recent Developments
11.7 C.R. Bard
11.7.1 C.R. Bard Company Information
11.7.2 C.R. Bard Overview
11.7.3 C.R. Bard Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 C.R. Bard Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 C.R. Bard Recent Developments
11.8 Baylis Medical Company
11.8.1 Baylis Medical Company Company Information
11.8.2 Baylis Medical Company Overview
11.8.3 Baylis Medical Company Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Baylis Medical Company Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Baylis Medical Company Recent Developments
11.9 BTG Vascular
11.9.1 BTG Vascular Company Information
11.9.2 BTG Vascular Overview
11.9.3 BTG Vascular Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 BTG Vascular Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BTG Vascular Recent Developments
11.10 Soundbite Medical Solutions
11.10.1 Soundbite Medical Solutions Company Information
11.10.2 Soundbite Medical Solutions Overview
11.10.3 Soundbite Medical Solutions Peripheral Chronic Total Occlusion Device Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Soundbite Medical Solutions Peripheral Chronic Total Occlusion Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Soundbite Medical Solutions Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peripheral Chronic Total Occlusion Device Industry Chain Analysis
12.2 Peripheral Chronic Total Occlusion Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peripheral Chronic Total Occlusion Device Production Mode & Process
12.4 Peripheral Chronic Total Occlusion Device Sales and Marketing
12.4.1 Peripheral Chronic Total Occlusion Device Sales Channels
12.4.2 Peripheral Chronic Total Occlusion Device Distributors
12.5 Peripheral Chronic Total Occlusion Device Customers
13 Market Dynamics
13.1 Peripheral Chronic Total Occlusion Device Industry Trends
13.2 Peripheral Chronic Total Occlusion Device Market Drivers
13.3 Peripheral Chronic Total Occlusion Device Market Challenges
13.4 Peripheral Chronic Total Occlusion Device Market Restraints
14 Key Findings in The Global Peripheral Chronic Total Occlusion Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Medtronic Plc
Boston Scientific Corporation
Avinger, Inc.
Cardinal Health
Koninklijke Philips N.V.
Cook Medical Incorporated
C.R. Bard
Baylis Medical Company
BTG Vascular
Soundbite Medical Solutions
*If Applicable.